Blockage of proposed bill that would protect in vitro fertilization (IVF) reignites debate over reproductive rights and health care access; ransomware attack leaves patients and providers stranded; people 65 years and older should get an additional booster for the COVID-19 vaccine, CDC says.
A new bill that would have ensured access to in vitro fertilization (IVF) treatment was blocked in the Senate, reigniting a contentious debate over reproductive rights and health care access, according to The New York Times. On Wednesday, a Republican senator blocked quick passage of a bill that would give federal protections for IVF and other fertility treatments after the ruling by the Alabama Supreme Court that frozen embryos should be considered children. As discussions unfold, both sides are gearing up for a potentially heated battle over the future of reproductive health care policy in the US this election season.
Health care providers and facilities continue to feel the impacts of a ransomware attack that has paralyzed payment systems and caused widespread disruption, according to Reuters. The cyberattack on Change Healthcare, a unit of UnitedHealth Group, sheds light on the vulnerability of critical infrastructure and raises concerns about the safety and security of sensitive patient data and health care transactions. Authorities are working to restore services while urging heightened cybersecurity measures to prevent future incidents.
The CDC's Advisory Committee on Immunization Practices has recommended COVID-19 vaccine booster shots for specific groups, including individuals 65 years and older, according to CNN. This decision comes amid concerns over waning immunity and the threat of new variants. Under the new recommendation, individuals 65 years and older can receive an additional dose of any updated COVID-19 vaccine at least 4 months after the previous shot.
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More